Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Nov. 02, 2013	Oct. 27, 2012
Cash flows from operating activities:
Net income (loss)	$ (13,881)	$ (37,028)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred financing costs	674	666
Depreciation and amortization	9,336	10,349
Provision for losses on accounts receivable	233	(51)
Share-based compensation expense	312	4,268
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	(38,269)	(22,192)
Inventories	(48,942)	(42,920)
Prepaid expenses and other assets	7,557	2,320
Accounts payable	28,177	25,173
Accounts payable-affiliates	(174)	1,957
Accrued expenses and other liabilities and other long-term liabilities	5,634	7,358
Net cash used in operating activities	(49,343)	(50,100)
Cash flows from investing activities:
Additions to property and equipment	(3,996)	(5,575)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	0	(44,949)
Net cash used in investing activities	(3,996)	(50,524)
Cash flows from financing activities:
Net borrowings under bank line of credit	53,867	71,191
Borrowings under affiliated notes payable to fund Parlux acquisition	0	30,000
Principal payments under capital lease obligations	(616)	(809)
Proceeds from exercise of stock options	40	83
Net cash provided by financing activities	53,291	100,465
Net decrease in cash and cash equivalents	(48)	(159)
Cash and cash equivalents at beginning of period	2,447	1,682
Supplemental Information:
Cash paid during the period for Interest	2,253	1,462
Cash paid during the period for Income taxes	27	327
Fair value of equity consideration given to acquire Parlux	$ 0	$ 89,563